Page last updated: 2024-09-03

aromadedrin and Cardiac Hypertrophy

aromadedrin has been researched along with Cardiac Hypertrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Cui, S; Cui, Y; Ding, S; Guo, H; Li, Y; Qin, W; Wang, H; Wu, D; Zhang, Y	1

Other Studies

1 other study(ies) available for aromadedrin and Cardiac Hypertrophy

Article	Year
Inhibition of cardiac hypertrophy by aromadendrin through down-regulating NFAT and MAPKs pathways. Biochemical and biophysical research communications, 2018, 12-02, Volume: 506, Issue:4 Topics: Animals; Antioxidants; Cardiomegaly; Cardiotonic Agents; Down-Regulation; Fibrosis; Flavonoids; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Myocytes, Cardiac; NFATC Transcription Factors; Phenylephrine; Pressure; Protein Biosynthesis	2018

Article

Year

Inhibition of cardiac hypertrophy by aromadendrin through down-regulating NFAT and MAPKs pathways.

Biochemical and biophysical research communications, 2018, 12-02, Volume: 506, Issue:4

Topics: Animals; Antioxidants; Cardiomegaly; Cardiotonic Agents; Down-Regulation; Fibrosis; Flavonoids; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Myocytes, Cardiac; NFATC Transcription Factors; Phenylephrine; Pressure; Protein Biosynthesis

2018